These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18676227)

  • 1. Pharmacokinetics of fusidic acid and cefepime in heart tissues: implications for a role in surgical prophylaxis.
    Kanellakopoulou K; Tselikos D; Giannitsioti E; Giamarellos-Bourboulis EJ; Apostolakis E; Lolas C; Giamarellou H
    J Chemother; 2008 Aug; 20(4):468-71. PubMed ID: 18676227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
    Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of ceftriaxone (1 or 2 grams intravenously) into mediastinal and cardiac tissues in humans.
    Martin C; Viviand X; Alaya M; Lokiec F; Ennabli K; Said R; Pecking M
    Antimicrob Agents Chemother; 1996 Mar; 40(3):812-5. PubMed ID: 8851621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.
    Huang V; Rybak MJ
    Antimicrob Agents Chemother; 2005 Jan; 49(1):302-8. PubMed ID: 15616309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Penetration of vancomycin in cardiac and mediastinal tissues in humans].
    Martin C; Alaya M; Mallet MN; Viviand X; Ennabli K; Said R; de Micco P
    Pathol Biol (Paris); 1994 May; 42(5):520-4. PubMed ID: 7824325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
    Memikoğlu KO; Bayar B; Kurt O; Cokça F
    Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the pharmacokinetics-pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selection.
    Okusanya OO; Tsuji BT; Bülitta JB; Forrest A; Bulik CC; Bhavnani SM; Fernandes P; Ambrose PG
    Diagn Microbiol Infect Dis; 2011 May; 70(1):101-11. PubMed ID: 21513848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusidic acid resistance in Staphylococcus aureus nasal carriage strains in nine European countries.
    den Heijer CD; van Bijnen EM; Paget WJ; Stobberingh EE
    Future Microbiol; 2014; 9(6):737-45. PubMed ID: 25046521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections].
    Reynaud AE; Espaze EP; Coste-Burel M; Richet H
    Pathol Biol (Paris); 1992 May; 40(5):466-70. PubMed ID: 1495828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone (1 g intravenously) penetration into abdominal tissues when administered as antibiotic prophylaxis during nephrectomy.
    Leone M; Albanèse J; Tod M; Savelli V; Ragni E; Rossi D; Martin C
    J Chemother; 2003 Apr; 15(2):139-42. PubMed ID: 12797390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery.
    Bergeron MG; Desaulniers D; Lessard C; Lemieux M; Després JP; Métras J; Raymond G; Brochu G
    Antimicrob Agents Chemother; 1985 Jun; 27(6):928-32. PubMed ID: 4026265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
    Peeters KA; Mascini EM; Blok HE; Sanders CJ
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2100-1. PubMed ID: 12448968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis.
    McLaws F; Chopra I; O'Neill AJ
    J Antimicrob Chemother; 2008 May; 61(5):1040-3. PubMed ID: 18299637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections.
    Liu Y; Geng W; Yang Y; Wang C; Zheng Y; Shang Y; Wu D; Li X; Wang L; Yu S; Yao K; Shen X
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):212-8. PubMed ID: 22066960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia.
    Lim KT; Teh CS; Yusof MY; Thong KL
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):112-8. PubMed ID: 24336696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility testing and clinical effect of fusidic acid in oxacillin-resistant Staphylococcus aureus infections.
    Liu CP; Lee CM; Su SC; Li YT
    J Microbiol Immunol Infect; 1999 Sep; 32(3):194-8. PubMed ID: 10637718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid turbidimetric assay for quantification of fusidic acid in a dermatological cream.
    Curbete MM; Salgado HR
    Talanta; 2016 Jun; 153():51-6. PubMed ID: 27130089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients.
    Cheatham SC; Shea KM; Healy DP; Humphrey ML; Fleming MR; Wack MF; Smith DW; Sowinski KM; Kays MB
    Int J Antimicrob Agents; 2011 Jan; 37(1):46-50. PubMed ID: 21074370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
    Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.